Steven Cohen Ionis Pharmaceuticals Inc Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 286,602 shares of IONS stock, worth $13.7 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
286,602
Previous 968,800
70.42%
Holding current value
$13.7 Million
Previous $49 Million
74.65%
% of portfolio
0.03%
Previous 0.12%
Shares
19 transactions
Others Institutions Holding IONS
# of Institutions
396Shares Held
122MCall Options Held
854KPut Options Held
464K-
Vanguard Group Inc Valley Forge, PA13.4MShares$640 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$635 Million0.35% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$466 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$396 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$271 Million0.04% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.76B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...